Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

DPYD anticorps

L’anticorps anti-DPYD Polyclonal produit chez le Lapin a été validé pour WB, IHC et ELISA. Il convient pour la détection de DPYD dans des échantillons provenant de Humain. }
N° du produit ABIN7178655
-15% Promotion 2026
372,13 €
437,80 €
Économisez 65,67 € (-15 %)
Plus frais de livraison 40,00 € et TVA
100 μL
Destination: France
Envoi sous 11 à 15 jours ouvrables

Aperçu rapide pour DPYD anticorps (ABIN7178655)

Antigène

Voir toutes DPYD Anticorps
DPYD (Dihydropyrimidine Dehydrogenase (DPYD))

Reactivité

  • 57
  • 18
  • 15
  • 1
  • 1
  • 1
Humain

Hôte

  • 57
  • 3
Lapin

Clonalité

  • 46
  • 14
Polyclonal

Conjugué

  • 26
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp DPYD est non-conjugé

Application

  • 47
  • 18
  • 15
  • 14
  • 14
  • 13
  • 13
  • 11
  • 7
  • 5
  • 3
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
  • Fonction

    DPYD Antibody

     Réactivité croisée

    Souris, Rat

    Purification

    Affinity purification

    Immunogène

    Recombinant protein of Human DPYD

    Isotype

    IgG
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    DPYD (Dihydropyrimidine Dehydrogenase (DPYD))

    Autre désignation

    DPYD

    Sujet

    Background: Dihydropyrimidine dehydrogenase (DPD, DPYD) catalyzes the initial and rate-limiting step in uracil and thymidine catabolism as well as catabolism of the chemotherapeutic drug 5-fluorouracil (5-FU) and its derivatives. DPYD deficiency, which results from mutations in the DPYD gene, causes errors in pyrimidine metabolism and potentially life-threatening side effects in cancer patients treated with 5-FU (reviewed in 1). As a result, ongoing work examines whether or how DPYD gene variation and protein expression can be used to predict 5-FU toxicity. Several genes that impart resistance to 5-FU were recently identified in human hepatocellular carcinoma (HCC). AEG-1, which is highly expressed in HCC, increases the expression of DPYD. DPYD is expressed more highly in HCC than in normal liver, and this is thought to be one mechanism of 5-FU resistance.

    Aliases: DHP antibody, DHPDHase antibody, Dihydropyrimidine dehydrogenase [NADP(+)] antibody, Dihydropyrimidine dehydrogenase [NADP+] antibody, Dihydropyrimidine dehydrogenase antibody, Dihydrothymine dehydrogenase antibody, Dihydrouracil dehydrogenase antibody, DPD antibody, DPYD antibody, DPYD_HUMAN antibody, MGC132008 antibody, MGC70799 antibody, OTTHUMP00000058954 antibody

    UniProt

    Q12882

    Pathways

    Ribonucleoside Biosynthetic Process
Vous êtes ici:
Chat with us!